期刊
CURRENT OPINION IN VIROLOGY
卷 2, 期 3, 页码 324-329出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.coviro.2012.04.003
关键词
-
类别
资金
- Intramural NIH HHS [ZIA AI005082-07, ZIA AI005081-07, ZIA AI005081-05, ZIA AI005082-06, Z01 AI005079-03, ZIA AI005079-05, ZIA AI005082-05, ZIA AI005081-06, Z01 AI005082-03, Z01 AI005081-03] Funding Source: Medline
Because of high case fatality proportions, person-to-person transmission, and potential use in bioterrorism, the development of a vaccine against ebolavirus remains a top priority. Although no licensed vaccine or treatment against ebolavirus is currently available, progress in preclinical testing of countermeasures has been made. Here, we will review ebolavirus vaccine candidates and considerations for their use in humans and wild apes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据